Prevalence of Pseudomonas aeruginosa associated chronic and acute respiratory infections and role of antibiotics as antibacterial agents against isolated pathogens
P. aeruginosa associated respiratory infections
DOI:
https://doi.org/10.17720/gz92z217Keywords:
Pseudomonas aeruginosa, , modern day superbug, quorum sensing, virulence factors, respiratory infections, , antibiotic resistance, sleep deprivation actorsAbstract
- aeruginosa is the commonest problematic pathogen for acute as well as chronic pulmonary infections in humans. Objectives: Screening of pathogenic P.aeruginosa from acute through Endotracheal tract secretions and Blood, chronic through Bronchoscopy samples. Identification of pathogenic strains by biochemical testing and virulence assays and Antibiotic resistance sensitivity test was done. Method: Blood, sputum and endotracheal samples were collected. Isolation of bacterial strains was done by cetrimide agar media and a number of morphological, biochemical and virulence tests were done for confirmation of the presence of P. aeruginosa. Antibiotic sensitivity was done to check the sensitivity of bacterial isolate against different antibiotics. Results: The recent study showed the percentile of Pseudomonas respiratory infections as, Type II Respiratory Failure 18%, Type I Respiratory Failure 9%, Pneumonia 22%, COPD 9%, Septicemia 15%, Pneumothorax & Emphysema and Co-pulmonale 4%, RDS 5%, Asthma 6%, Chest filial injury and pulmonary odema was 2%. Conclusion: Rate of pulmonary infections due to P. aeruginosa was high among patients and antibiotic sensitivity test resulted that P. aeruginosa was a multidrug resistant pathogen and only few percent of antibiotics were effective against this pathogenic bacteria.
Downloads
References
I. Momenah A M, Bakri R A, Jalal N A, Ashgar S S, Felemban R F, Bantun F, Al-Said H M. Antimicrobial resistance pattern of Pseudomonas aeruginosa: An 11-year experience in a tertiary care hospital in Makkah, Saudi Arabia. Infection and Drug Resistance 2023; 4113-4122.
II. Diggle S P, Whiteley M. Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat. Microbiology 2020; 166(1) 30-33.
III. Chadha J, Harjai K, Chhibber S. Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing. Environmental microbiology 2022; 24(6) 2630-2656.
IV. Kostylev, M., Smalley, N. E., Chao, M. H., & Greenberg, E. P. (2023). Relationship of the transcription factor MexT to quorum sensing and virulence in Pseudomonas aeruginosa. Journal of Bacteriology, 205(12), e00226-23.
V. Jurado-Martín I, Sainz-Mejías M, McClean S. Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. International journal of molecular sciences 2021; 22(6) 3128.
VI. Tuon F F, Dantas L R, Suss P H, Tasca Ribeiro V S. Pathogenesis of the Pseudomonas aeruginosa biofilm: a review. Pathogens 2022; 11(3) 300.
VII. Urgancı N N, Yılmaz N, Alaşalvar G K, Yıldırım Z. Pseudomonas aeruginosa and its pathogenicity. Turkish Journal of Agriculture-Food Science and Technology 2022; 10(4) 726-738.
VIII. Munir S, Shah A A, Shahid M, Manzoor I, Aslam B, Rasool M H, Khurshid M. Quorum sensing interfering strategies and their implications in the management of biofilm-associated bacterial infections. Brazilian Archives of Biology and Technology 2020; 63 e20190555.
IX. Swetha T K, Priya A, Pandian S K. Natural molecules against QS-associated biofilm formation of pathogens. In Microbial and natural macromolecules 2021; (pp. 317-348). Academic Press.
X. Aldawsari M F, Khafagy E S, Saqr A A, Alalaiwe A, Abbas H A, Shaldam M A, Goda R M. Tackling virulence of Pseudomonas aeruginosa by the natural furanone sotolon. Antibiotics 2021; 10(7): 871.
XI. Sırıken B, Öz V, Erol İ. Quorum sensing systems, related virulence factors, and biofilm formation in Pseudomonas aeruginosa isolated from fish. Archives of Microbiology 2021; 203 1519-1528.
XII. Wang S, Feng Y, Han X, Cai X, Yang L, Liu C, Shen L. Inhibition of virulence factors and biofilm formation by wogonin attenuates pathogenicity of Pseudomonas aeruginosa PAO1 via targeting pqs quorum-sensing system. International Journal of Molecular Sciences 2021; 22(23) 12699.
XIII. Mohamed E A, Nawar A E, Hegazy E E. Insight into quorum sensing genes LasR and RhlR, their related virulence factors and antibiotic resistance pattern in Pseudomonas aeruginosa isolated from ocular Infections. Microbes and Infectious Diseases 2023; 4(2) 575-589.
XIV. Trottier M C, de Oliveira Pereira T, Groleau M C, Hoffman L R, Dandekar A A, Déziel E. The end of the reign of a “master regulator’’? A defect in function of the LasR quorum sensing regulator is a common feature of Pseudomonas aeruginosa isolates. Mbio 2024; 15(3) e02376-23.
XV. Chellappan D K, Prasher P, Shukla S D, Yee T W, Kah T K, Xyan T W, Dua K. Exploring the role of antibiotics and steroids in managing respiratory diseases. Journal of Biochemical and Molecular Toxicology 2022; 36(10) e23174.
XVI. Raghav, H., Tayal, P., Das, R., & Mehta, D. K. (2022). Appropriate Use of Antibiotics for the Management of Respiratory Tract Infections. Infectious Disorders Drug Targets, 22(5), e180122200335-e180122200335.
XVII. Sathe N, Beech P, Croft L, Suphioglu C, Kapat A, Athan E. Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment. Infectious Medicine 2023; 2(3) 178-194.
XVIII. Baran Ş Y, Törer B, Kalaycı H, Durdağ G D. The effect of the cause of delivery on neonatal outcomes in early preterm deliveries. Journal of Fetal Medicine 2019; 6(03) 139-145.
XIX. Bulimba M, Cosmas J, Abdallah Y, Massawe A, Manji K. Early outcomes of preterm neonates with respiratory distress syndrome admitted at Muhimbili National Hospital, a prospective study. BMC pediatrics 2022; 22(1) 731.
XX. Norman M, Jonsson B, Wallström L, Sindelar R. Respiratory support of infants born at 22–24 weeks of gestational age. In Seminars in Fetal and Neonatal Medicine 2022, April; (Vol. 27, No. 2, p. 101328). WB Saunders.
XXI. Bonell A, Azarrafiy R, Huong V T L, Viet T L, Phu V D, Dat V Q, Nadjm B. A systematic review and meta-analysis of ventilator-associated pneumonia in adults in Asia: an analysis of national income level on incidence and etiology. Clinical Infectious Diseases (2019); 68(3) 511-518.
XXII. De Luca D, Autilio C, Pezza L, Shankar-Aguilera S, Tingay D G, Carnielli V P. Personalized medicine for the management of RDS in preterm neonates. Neonatology 2021; 118(2) 127-138.
XXIII. Malhotra S, Hayes Jr D, Wozniak D J. Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface. Clinical microbiology reviews 2019; 32(3) 10-1128.
XXIV. Armbruster C R, Coenye T, Touqui L, Bomberger J M. Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis. Journal of Cystic Fibrosis 2020; (19) S47-S53.
XXV. Bell S C, Mall M A, Gutierrez H, Macek M, Madge S, Davies J C, Ratjen F. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine 2020; 8(1) 65-124.
XXVI. Greenwald M A, Wolfgang M C. The changing landscape of the cystic fibrosis lung environment: from the perspective of Pseudomonas aeruginosa. Current Opinion in Pharmacology 2022; 65 102262.
XXVII. Thi M T T, Wibowo D, Rehm B H. Pseudomonas aeruginosa biofilms. International journal of molecular sciences 2020; 21(22) 8671.
XXVIII. Elfadadny A, Ragab R F, AlHarbi M, Badshah F, Ibáñez-Arancibia E, Farag A, Nageeb W M. Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Frontiers in Microbiology 2024; 15 1374466.
XXIX. Shatti H H, Al-Saeed W M, Nader M I. Effect biofilm formation in Pseudomonas aeruginosa resistance to antibiotic. Mustansiriya Medical Journal 2022; 21(1) 13-17.
XXX. Hossain M, Ahammed M A, Sobuj S, Shifat S, Somadder P. Cellulase producing bacteria isolation, screening and media optimization from local soil sample. American Journal of Microbiological Research 2021; 9(3) 62-74.
XXXI. Ezeador C O, Ejikeugwu P C, Ushie S N, Agbakoba N R. Isolation, identification and prevalence of Pseudomonas aeruginosa isolates from clinical and environmental sources in Onitsha Metropolis, Anambra State. European Journal of Medical and Health Sciences 2020; 2(2).
XXXII. Kumari V J. Analysis the antibacterial activity Pseudomonas aeruginosa pigment on Escherichia coli. Nveo-natural Volatiles & Essential Oils Journal NVEO 2021; 3714-3723.
XXXIII. Sharmin S, Nahar A, Alamgir F, Fahim I. Prevalence and Antibiotic Sensitivity Pattern of Pseudomonas Aeruginosa Isolates from Urine Samples in A Tertiary Care Hospital. Dhaka Shishu (Children) Hospital Journal 2021; 37(1) 40-44.
XXXIV. Becerra S C, Roy D C, Sanchez C J, Christy R J, Burmeister D M. An optimized staining technique for the detection of Gram positive and Gram negative bacteria within tissue. BMC research notes, 2016; 9 1-10.
XXXV. Vasapolli R, Ailloud F, Suerbaum S, Neumann J, Koch N, Macke L, Schulz C. Intraprocedural gastric juice analysis as compared to rapid urease test for real-time detection of Helicobacter pylori. World Journal of Gastroenterology 2023; 29(10) 1638.
XXXVI. Castilla-Sedano A J, Zapana-García J, Valdivia-Del Águila E, Padilla-Huamantinco P G, Guerra D G. Quantification of early biofilm growth in microtiter plates through a novel image analysis software. Journal of Microbiological Methods 2024; 223 106979.
XXXVII. Meenakshi S, Hiremath J, Meenakshi M H, Shivaveerakumar S. Actinomycetes: Isolation, Cultivation and its Active Biomolecules. Journal of Pure & Applied Microbiology 2024; 18(1).
XXXVIII. Wang L, Cao X, Pei H, Liu P, Song Y, Wu Y. Anti-Biofilm Activity of Chlorogenic Acid against Pseudomonas Using Quorum Sensing System. Foods 2023; 12(19) 3601.
XXXIX. Matuschek E, Copsey-Mawer S, Petersson S, Åhman J, Morris T E, Kahlmeter G. The European committee on antimicrobial susceptibility testing disc diffusion susceptibility testing method for frequently isolated anaerobic bacteria. Clinical Microbiology and Infection 2023; 29(6) 795-e1.
XL. Al-Maeni M A R. Detecting the Variation in the lasI Gene and Their Relation with Biofilm in Pseudomonas aeruginosa Isolates. Iraqi Journal of Science 2024; 79-89.
XLI. Mac Aogáin M, Xaverius Ivan F, Jaggi T K, Richardson H, Shoemark A, Narayana J K, Chotirmall S H.. Airway “resistotypes” and clinical outcomes in bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2024; 210(1) 47-62.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
